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Abstract
The heteropentameric condensin complexes have been shown to participate in mitotic chromosome condensation and to
be required for unperturbed chromatid segregation in nuclear divisions. Vertebrates have two condensin complexes,
condensin I and condensin II, which contain the same structural maintenance of chromosomes (SMC) subunits SMC2 and
SMC4, but differ in their composition of non–SMC subunits. While a clear biochemical and functional distinction between
condensin I and condensin II has been established in vertebrates, the situation in Drosophila melanogaster is less defined.
Since Drosophila lacks a clear homolog for the condensin II–specific subunit Cap-G2, the condensin I subunit Cap-G has
been hypothesized to be part of both complexes. In vivo microscopy revealed that a functional Cap-G-EGFP variant shows a
distinct nuclear enrichment during interphase, which is reminiscent of condensin II localization in vertebrates and contrasts
with the cytoplasmic enrichment observed for the other EGFP-fused condensin I subunits. However, we show that this
nuclear localization is dispensable for Cap-G chromatin association, for its assembly into the condensin I complex and,
importantly, for development into a viable and fertile adult animal. Immunoprecipitation analyses and complex formation
studies provide evidence that Cap-G does not associate with condensin II–specific subunits, while it can be readily detected
in complexes with condensin I–specific proteins in vitro and in vivo. Mass-spectrometric analyses of proteins associated with
the condensin II–specific subunit Cap-H2 not only fail to identify Cap-G but also the other known condensin II–specific
homolog Cap-D3. As condensin II–specific subunits are also not found associated with SMC2, our results question the
existence of a soluble condensin II complex in Drosophila.
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Introduction
Chromosome condensation is a critical process ensuring faithful
distribution of the replicated genetic information onto the
daughter cells. While the exact mechanism underlying the
longitudinal compaction of the dispersed interphase chromatin
into the rod-like and sturdy metaphase chromosomes is still subject
of intense research, the participation of the condensin complexes
in this process has been thoroughly demonstrated (for review see
[1–3]). However, while condensin is clearly required and sufficient
for compaction of sperm chromatin incubated in Xenopus laevis egg
extracts [4,5], the phenotypes observed after condensin depletion
in other systems suggest the existence of alternative mechanisms
mediating chromatin compaction. Condensin depletion in verte-
brate cells, worms and flies does affect the structure of mitotic
chromosomes, but compaction of chromatin is only slightly
impaired. The extent of this compaction phenotype varies by
the organism studied and the experimental system used (for review
see [3]). However, in all cases, persistent interconnections of
chromatin fibres can be observed in anaphase (so-called anaphase
bridges), resulting in severe problems during chromatid segrega-
tion in mitosis. Thus, condensin has a role in resolving chromatin
bridges present between the replicated chromatids.
Plants and animals harbour two condensin complexes, both
containing the structural maintenance of chromosomes (SMC)
proteins SMC2 and SMC4, but differing in their non-SMC
regulatory subunits. Condensin I complexes contain the subunits
Cap-D2, Cap-G and Cap-H (also called Barren in Drosophila),
while condensin II complexes contain the related subunits Cap-
D3, Cap-G2 and Cap-H2. Cap-H and Cap-H2 belong to the
kleisin family of proteins which are characterized by their ability to
bind to the head domains of SMC protein dimers [6]. Cap-G,
Cap-G2, Cap-D2 and Cap-D3 contain in their N-terminal parts
extended regions of Huntingtin, elongation factor 3, A-subunit of
protein phosphatase 2A, TOR1 lipid kinase (HEAT) repeats,
which are thought to mediate protein-protein interactions [7]. In
vertebrates, both condensin complexes play essential roles and
collaborate in structuring of mitotic chromosomes and in ensuring
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their unperturbed segregation. Interestingly, the two complexes
fulfil non-overlapping functions as exemplified by distinct pheno-
types upon depletion of either condensin I or condensin II-specific
subunits [8–10], by their alternating association with mitotic
chromosomes [11,12], or by their different localization in
interphase cells: Condensin I-specific subunits are enriched in
the cytoplasm, while condensin II-specific subunits can be found
primarily in the nucleus [9–11]. Within the eukaryotic kingdom,
the composition of the condensin complexes found in different
species is not uniform. Fission and budding yeast harbour
homologs only for condensin I, as do e.g. ciliates and kinetoplastids
(for review see [3]). C. elegans, on the other hand, contains three
condensin complexes, one of which (condensin IDC) has specialized
to function in dosage compensation in hermaphrodites [13]. In
Drosophila melanogaster, condensin I is present, but for condensin II
only the subunits Cap-H2 and Cap-D3 can be identified. No gene
encoding the condensin II-specific subunit Cap-G2 is apparent in
the genome. This has led to the speculation that Drosophila Cap-G
might be a component of both complexes, just as SMC2 and
SMC4 [14–16]. The essential role for all condensin I-specific
subunits in mitotic proliferation is well established [14,17–22]. On
the other hand, loss-of-function mutations of the Drosophila genes
encoding Cap-H2 and Cap-D3 are viable, indicating that their
function is dispensable for mitotic proliferation [18,23,24].
However, Cap-D3 and Cap-H2 mutant males are sterile, and
cytological as well as genetic evidence clearly indicates a role
during male meiosis for these two subunits [23]. Interestingly,
mutations in Cap-H2 have also been shown to prevent the dispersal
of nurse cell polytene chromosomes, which are present for a short
developmental period during oogenesis, and to enhance transvec-
tion phenomena. Conversely, Cap-H2 overexpression leads to
dispersal of the polytene chromosomes in larval salivary glands
and in addition suppresses transvection [24]. These results suggest
that Cap-H2 negatively regulates chromosome associations and
additional genetic evidence indicates that this function is
dependent on Cap-D3 [24]. Moreover, Cap-D3 has been shown
to interact with the Drosophila Retinoblastoma (Rb)-protein
homolog Rbf and the two proteins colocalize on the regulatory
regions for transcription of the antimicrobial peptide (AMP) genes,
thereby influencing innate immunity [16,25]. Thus, the Drosophila
condensin II subunits Cap-H2 and Cap-D3 perform roles in
regulating gene expression, as has been demonstrated for
condensin complexes in other studies [20,21,26,27]. However,
whether these functions are performed in the context of a physical
protein complex containing SMC2, SMC4, Cap-H2, Cap-D3 and
possibly Cap-G is unknown. While biochemical evidence for the
existence of a soluble condensin I complex has been published
[18], the existence and protein composition of a soluble condensin
II-like complex in Drosophila is uncertain.
Here, we have analyzed in detail the localization behaviour and
complex formation capabilities of Drosophila Cap-G in vivo and in
vitro to test the hypothesis, whether it might be a common
component of both condensin complexes in Drosophila. The
comparison of the localization and dynamics of various fluores-
cently tagged, functional condensin subunits highlights the fact
that Cap-G indeed behaves differently from other condensin I-
complex components. However, complex formation studies
strongly argue against Cap-G being associated with condensin
II-specific components. Furthermore, immunoprecipitation anal-
yses consistently provide evidence for soluble condensin I
complexes, but fail to support the presence of native soluble
condensin II complexes in vivo and indicate a strongly reduced
complex formation potential in vitro. Thus, while we cannot
exclude the assembly of condensin II-like complexes specifically on
chromatin in specialized cell types, our data argue against the
existence of an abundant and stable soluble condensin II complex
in Drosophila.
Results
Localization of Drosophila condensin subunits during the
cell cycle
In interphase, vertebrate condensin I subunits are primarily
cytoplasmic, while condensin II subunits are primarily nuclear [9–
11]. Consistently, Drosophila Barren/Cap-H and Cap-H2 have also
been found to be cytoplasmic or nuclear enriched, respectively
[24,28]. Towards a comparative description of the localization
behavior of Drosophila condensin subunits in the living organism,
we have generated EGFP-fused variants of the condensin subunits
Cap-D2, SMC2 and Cap-G (Figure S1A). EGFP-Cap-D2 should
label exclusively condensin I-complexes, while SMC2h-EGFP is
expected to occur in both condensin I and condensin II. As no
condensin II-specific Cap-G2 subunit has been identified in
Drosophila, Cap-G has been hypothesized to be also part of both
condensin complexes [14–16]. Thus, Cap-G localization may
provide a hint as to whether it is part of only condensin I or both
condensin complexes in Drosophila.
All three transgene constructs are expressed under control of the
flanking genomic regulatory sequences and quantification of the
expression levels in early embryogenesis reveal a ratio of transgene
products of approximately 1:4:8 (Cap-G-EGFP:SMC2h-EGF-
P:EGFP-Cap-D2; Figure S1B). Despite these differences, all
transgenes encode biologically functional products as the presence
of single copies of the transgenes can complement the lethality
associated with loss-of-function-mutations in the respective genes
(Table S1 and data not shown). Analysis of living embryos
progressing through the divisions of the syncytial blastoderm
revealed that during interphase, SMC2h-EGFP and EGFP-Cap-
D2 are enriched in the cytoplasm, as has been reported previously
for the condensin I - specific subunit Cap-H/Barren (Figure 1A;
Videos S1 and S2; [28]). In contrast, Cap-G-EGFP is nuclear
enriched in interphase, reminiscent of condensin II localization in
Author Summary
The accurate duplication and segregation of chromosomes
during cell divisions are prerequisites for ensuring genetic
stability within an individual organism and in entire
populations. Among the many components involved in
regulating these processes, a protein complex called
condensin plays a crucial role in shaping mitotic chromo-
somes, so that they can be faithfully distributed. Many
organisms contain two of these condensin complexes
(condensin I and II), which both have been shown to be
required for accurate chromosome distribution. In the fly
Drosophila melanogaster, condensin II appears to lack one
of its components, called Cap-G2. We have tested the
hypothesis whether the corresponding component of
condensin I (Cap-G) might also participate in the assembly
of condensin II. Careful analyses of complexes formed in
the living organism or in the test tube argue against Cap-G
being part of condensin II. Moreover, our results question
the very existence of a soluble condensin II complex in
flies, as opposed to other organisms. Surprisingly, a
substantially truncated variant of the essential Cap-G still
supports development of living and fertile flies. As this
variant localizes within the cell differently from full-length
Cap-G, our results show that localization of a protein does
not always determine its function.
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Figure 1. Localization of Drosophila condensin subunits during the cell cycle. (A) Living embryos expressing gHis2Av-mRFP1 together with
gSMC2h-EGFP (upper panel), gEGFP-Cap-D2 (middle panel), or gCap-G-EGFP (lower panel) were imaged while progressing through nuclear cycle 12.
Representative images for indicated time points in min are shown (t = 0.0 min, anaphase onset). Note that SMC2h-EGFP and EGFP-Cap-D2 are
enriched in the cytoplasm during interphase, while Cap-G-EGFP is nuclear enriched. Scale bar is 5 mm. (B) Fluorescence intensities of EGFP-Cap-D2
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vertebrates (Figure 1A, Video S3). All three EGFP-fused subunits
rapidly associate with condensing chromatin at early stages of
mitosis. However, Cap-G-EGFP associates with chromatin slightly
earlier than EGFP-Cap-D2 and SMC2h-EGFP, which might be
due to its preferential nuclear localization in interphase. All
condensin subunits leave chromatin during late anaphase/early
telophase (Figure 1A; Videos S1, S2, S3). As the different
condensin subunits exhibit distinct localization patterns during
interphase, and differ in their chromatin association kinetics, we
scrutinized the dynamics of mitotic chromatin association of these
subunits during cycle 12 of the syncytial divisions. To this end, we
performed quantitative measurements of the EGFP fluorescence
signals and normalized them to the simultaneously recorded
fluorescence measurements of the mRFP1-fused histone variant
His2Av, which was also expressed in these embryos. The data
revealed that Cap-G-EGFP is loaded maximally already at nuclear
envelope breakdown, a time-point when the EGFP-fused subunits
Cap-D2 and Cap-H/Barren (data from [28]) are just beginning to
associate with chromatin (Figure 1B). Interestingly, SMC2h-EGFP
loading appears even more delayed (half-maximal association of
SMC2 is 22.5 min before anaphase onset vs. 23.5 min for Cap-
D2 and Cap-H/Barren; Figure 1B). Similar loading kinetics are
observed, when SMC2h-EGFP chromatin association was deter-
mined in an SMC2 mutant background, ruling out the possibility
that the presence of endogenous SMC2 significantly delays
incorporation of the EGFP-fused variant (Figure S2). For all
analyzed subunits, maximal chromatin association levels are
achieved during late metaphase/early anaphase. During exit from
mitosis, the four condensin subunits delocalize from chromatin
with almost identical kinetics (Figure 1B).
To assess, which regions of Cap-G mediate the subcellular
localization during the cell cycle, we expressed various EGFP-
fused deletion constructs under GAL4/UAS-control in early
embryos and analyzed the localization behavior of the fusion
proteins while cells were progressing through epidermal mitosis 14
(Figure 2A). Computational analyses predict nuclear localization
signals (NLS) at positions 1072, 1162, and 1210. Consistently, a C-
terminal Cap-G fragment (Cap-GC; aa 958–1351) encompassing
these signals is strongly nuclear enriched in interphase. At nuclear
envelope breakdown, the fusion protein distributes throughout the
cell (Figure 2B, Video S4). During early to mid mitosis, Cap-GC-
EGFP associates only very weakly with chromatin. However,
beginning with late anaphase, Cap-GC-EGFP accumulates on the
segregating chromatids (Figure 2B, Video S4). The construct Cap-
GNM-EGFP (aa 1–977) lacks the C-terminal region with the NLS,
but retains an extended region predicted to form HEAT-repeats
and it displays a complementary localization behavior when
compared to Cap-GC-EGFP. In interphase, this Cap-G variant is
primarily localized in the cytoplasm, but approximately 20–40 sec
after nuclear envelope breakdown, it associates rapidly and
efficiently with mitotic chromatin (Figure S3). Starting with
anaphase, Cap-GNM-EGFP dissociates from chromatin similar to
full length Cap-GFL-EGFP (Figure 2B, Video S5) and as was
observed for the other condensin subunits (Figure 1B; [28]).
To assess, whether the mitotic localization behavior of Cap-
GNM-EGFP reflects its potential to form complexes with the other
condensin subunits, we performed immunoprecipitation analyses.
Extracts were prepared from embryos expressing various EGFP-
fused Cap-G variants followed by precipitation using anti-EGFP
antibodies. Proteins bound to the beads were eluted in two steps,
with the second being more stringent. Four prominent protein
bands in the high molecular weight range can be detected on silver
stained gels in the first round eluates of both Cap-GFL-EGFP and
Cap-GNM-EGFP-coupled beads (Figure 2C). The identity of two
of the bands was confirmed as Cap-D2 and Cap-H/Barren by
immunoblot analysis (Figure S4). Based on their migration
behavior, the first and third bands were suspected to correspond
to SMC4 and SMC2, respectively. This assignment was corrob-
orated by mass-spectrometric analyses of Cap-GFL-EGFP immu-
noprecipitates (see below). The antibody-bound EGFP-fused Cap-
G variants were primarily eluted under more stringent conditions
(Figure 2C). Cap-GC-EGFP immunoprecipitates did not contain
the other condensin I subunits in significant amounts, as did not
the precipitates of a Cap-GNM-EGFP- variant with a further N-
terminal truncation of 242 amino acids (Cap-GNM4-EGFP). This
latter variant does not localize to mitotic chromatin and it is
distributed in interphase throughout the cell (Figure S5). The
HEAT repeats predicted to form in the N-terminal region of Cap-
G are implicated in protein-protein interactions [7]. Thus, binding
of Cap-G to the condensin complex may be mediated via the
HEAT-repeat motifs, since Cap-GNM4-EGFP lacking a large part
of this domain is not able to precipitate Cap-D2 or Cap-H/
Barren. However, the N-terminal 242 amino acids are not
sufficient for efficient association with mitotic chromatin, since
the variant Cap-GNM1-EGFP, which encompasses the region of aa
1–848, is primarily cytoplasmic in interphase like Cap-GNM-
EGFP, and associates only very weakly with chromatin during
mitosis (Figure S5). We conclude that the C-terminal third of Cap-
G contains nuclear localization sequences, but it is dispensable for
mitotic chromatin association. Moreover, the HEAT-repeat region
as well as the stretch encompassing aa 848–977 within the N-
terminal two-thirds of Cap-G are required for binding to mitotic
chromatin, most probably by virtue of their mediating the
assembly into condensin complexes.
Cap-G-EGFP co-localizes in interphase with HP-1 and
initiates chromatin loading at centromeres
We have noticed that during interphase, Cap-GFL-EGFP and
Cap-GC-EGFP are not homogeneously distributed in the nucle-
oplasm. As the patchy appearance of Cap-G signals is reminiscent
of heterochromatin distribution in these nuclei, we analyzed
embryos expressing EGFP-fused Cap-GFL or Cap-GC concomi-
tant with a red fluorescently labeled variant of heterochromatin
protein 1 (mRFP1-HP1) (Figure 3A). HP1 binds to histone H3
methylated at lysine 9 and is thus a marker for heterochromatin
distribution in interphase cells [29]. In vivo microscopy of embryos
progressing through epidermal cycle 14 revealed that the two Cap-
G variants indeed largely co-localize with mRFP1-HP1 during
interphase, indicating heterochromatin association of Cap-G
(Figure 3A). During mitosis, mRFP1-HP1 dissociates from
chromatin, as has been previously observed with fixed material
(arrowheads in Figure 3A; [30]). This observation, together with
the fact that Cap-GC associates with chromatin in late mitosis
when mRFP1-HP1 is still absent, indicates that Cap-G chromatin
(orange), Cap-G-EGFP (purple), and SMC2h-EGFP (blue) were determined for selected nuclei in each frame and are plotted as relative intensities per
nucleus. Data series were aligned accordingly to anaphase onset (t0 = last metaphase). Data sets from a total of 15 to 37 nuclei from seven to 15
embryos were aligned. The values for Cap-H/Barren (green) are taken from Oliveira et al., 2007 [28]. The times of initiation of chromatin condensation
(ICC) and NEBD are indicated by the dotted and dashed red lines, respectively. The red arrows with the roman type numerals correspond to the
images shown in (A).
doi:10.1371/journal.pgen.1003463.g001
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association does not depend on the presence of HP1. While Cap-G
clearly co-localizes with heterochromatin in interphase, it does not
appear to be physically associated with HP1 in a common protein
complex as HP1 cannot be co-precipitated with Cap-G (Figure
S6).
Embedded within the heterochromatin are the centromeres. As
enrichment of other condensin subunits in centromeric regions has
been demonstrated [11,17,31–33] and a genetic and physical
interaction of Cap-G with the centromeric H3 variant Cid has
been established [14], we scrutinized the dynamics of Cap-G
chromatin association. To this end, we analyzed the localization
behavior of Cap-GFL-EGFP in comparison with Cid-mRFP1 in
embryos progressing through cycle 14. Indeed, early chromatin
accumulation of Cap-GFL-EGFP occurs in nuclear regions where
Cid-mRFP1 signals can be detected (Figure 3B). Similar dynamics
are observed when embryos progress through syncytial cycle 12,
and quantitation reveals an approximately twofold enrichment of
Cap-GFL-EGFP in centromere-proximal vs. centromere-distal
regions in early stages of Cap-G chromatin association (Figure
S7). Thus, our observations are consistent with a model in which
Cap-G first binds to centromeric regions and then spreads into the
adjacent heterochromatin.
Interphase nuclear localization of Cap-G is dispensable
for condensin function during the cell cycle and
development
The C-terminus of Cap-G is required for nuclear localization
and sufficient to confer heterochromatic enrichment during
interphase. The N-terminal two-thirds of Cap-G, on the other
hand, are sufficient for efficient chromatin localization during
mitosis and for assembly within the condensin I holocomplex. To
assess the relevance of the functional features contributed by the
Cap-G C-terminus, we generated individuals expressing Cap-GNM
or Cap-GNM-EGFP as sole source for this condensin subunit in a
Cap-G1/Cap-G6 trans-heterozygous mutant background. Loss-of-
function mutations in Cap-G are embryonic lethal [14,20].
Expression of Cap-GFL-EGFP, either under control of the genomic
regulatory sequences or under GAL4/UAS control using the
ubiquitous da-GAL4 driver, gave rise to viable and fertile adults
demonstrating the biological functionality of these constructs
(Table S1). Surprisingly, adult flies were also obtained with high
efficiency by ubiquitous expression of two independent pUAST-
based UAS-Cap-GNM-EGFP-transgene insertions in the same trans-
heterozygous Cap-G mutant background. As pUAST does not
direct expression in the female germline, female fertility could not
be assessed in these cases. However, expression from the Cap-GNM-
EGFP transgene contained in a pUASP-based vector, which also
allows expression in the female germline [34], restored fertility in
both sexes (Table S1). Immunoblot analysis confirmed that these
animals lacked expression of endogenous Cap-G and survived
solely due to the expression of the C-terminally truncated Cap-G
variants (Figure S8A). To assess, whether the C-terminally
truncated Cap-GNM variant also fails to localize to interphase
nuclei in the absence of competing full-length Cap-G, we analyzed
Cap-GNM-EGFP localization in the rescue situation. Cap-GNM-
EGFP is excluded from the nuclei in interphase also in a Cap-G
mutant background, and it does not bind to chromatin in
prophase, ruling out the possibility that the presence of competing
full-length Cap-G might prevent early chromatin association of the
Cap-GNM variant (Figure S8B and see also Figure S10C). Not all
Cap-GNM transgenes complemented the Cap-G mutant phenotype
efficiently. Fertility was only observed after crosses of rescued
individuals with wild type flies, and many eggs laid by Cap-GNM
rescued mothers displayed developmental defects (data not shown).
Therefore, it was not possible to establish stable rescue stocks. We
conclude nevertheless that the C-terminal 374 amino acids of Cap-
G are not absolutely critical for condensin function required for
development from the fertilized egg to a fertile adult. While the
full-length protein rescues with higher efficiency than the C-
terminal truncated version when expressed at comparable levels
(Table S1; genomic transgenes), the development of fertile adult
animals is still possible when the C-terminal domain of Cap-G is
lacking. As this C-terminal part contains the NLS, nuclear
enrichment of Cap-G during interphase is dispensable for
condensin function in the cell cycle and during development.
Cap-G is not associated with condensin II–specific
subunits in vivo
Due to the lack of an obvious Cap-G2 homolog encoded in the
Drosophila genome, Cap-G has been hypothesized to be part of
both condensin subunits, just as SMC2 and SMC4 [14–16]. In the
anti-Cap-GFL-EGFP immunoprecipitates shown in Figure 2C,
four prominent high molecular weight bands are evident, which
were assigned to the condensin I-specific subunits and the two
SMC’s. As the condensin II-specific subunits Cap-H2 and Cap-D3
might not have been abundant enough in the analyzed extracts to
be detected by silver staining, we performed additional immuno-
precipitation experiments followed by sensitive mass spectrometric
(MS) analysis of the precipitates. We have used a variety of strains
expressing condensin subunits fused with fluorescent proteins,
which were precipitated with the appropriate antibodies
(Figure 4A). First, we prepared extracts from early embryos or
from ovaries isolated from individuals expressing Cap-GFL-mRFP1
under the control of the genomic regulatory sequences. Like the
EGFP-fused Cap-G variant, mRFP1-fused Cap-G is biologically
Figure 2. The N-terminal two-thirds of Cap-G are sufficient for interaction with chromatin and condensin I subunits. (A) Left panel.
Schematic drawing of the analyzed EGFP-fused Cap-G-fragments. Full-length Cap-G (Cap-GFL) encompasses 1351 aa. HEAT-repeats (pale pink) are
predicted by SMART between residues 50 and 553, and nuclear import signals (red bars) are predicted by PSORT at aa positions 1072, 1162 and 1210.
Right panel. The localization characteristics of the Cap-G constructs as well as their ability to complement the lethality associated with Cap-G loss-of-
function mutants is indicated. (B) Subcellular localization and chromatin association of different EGFP-fused Cap-G-fragments observed in living
embryos progressing through epidermal mitosis14. Expression of different UAST-Cap-G-EGFP transgenes was driven by a4-tub-GAL4-VP16. Cap-GC-
EGFP is enriched inside the nuclei during interphase but does not associate with chromatin during early stages of mitosis. In contrast, Cap-GNM-EGFP
is mainly cytoplasmic during interphase and associates with mitotic chromatin immediately after NEBD. Individual frames of representative time lapse
movies are shown with time points indicated in min (t = 0, anaphase onset). Scale bar is 5 mm. (C) Extracts from 3–6 h old embryos expressing various
EGFP-fused Cap-G-fragments driven by a4-tub-GAL4-VP16 were subjected to immunoprecipitation with rabbit-anti-EGFP antibodies. Bound proteins
were eluted in two steps with increasing stringency. Precipitates were separated by SDS-PAGE and subjected to silver staining. The identity of Cap-H/
Barren and Cap-D2 was confirmed by immunoblotting, SMC2 and SMC4 were assigned according to their expected molecular weight (indicated by
asterisks). The condensin I subunits were efficiently precipitated by both Cap-GFL-EGFP and Cap-GNM-EGFP and were eluted during the first step (IP 1st
elution), while they were not significantly precipitated by Cap-GNM4-EGFP and Cap-GC-EGFP. The second elution step (IP 2nd elution) mainly reveals
the recovery of the EGFP-fused Cap-G-fragments (filled circles). Note that Cap-GFL-EGFP and Cap-GNM-EGFP migrate at the same position in the SDS-
polyacrylamide gel as SMC4 and SMC2, respectively.
doi:10.1371/journal.pgen.1003463.g002
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functional as it rescues Cap-G mutants to vitality and fertility (data
not shown). After immunoprecipitation using anti-mRFP1 anti-
bodies, aliquots of the eluates were separated on an SDS-
polyacrylamide gel and stained with silver to visualize the
precipitated proteins (Figure 4B). In a parallel experiment, lanes
with the eluates were stained with colloidal Coomassie Blue, cut
into seven slices each and processed for MS. This procedure
allowed a comprehensive evaluation of the proteins associated with
the precipitated bait. As a negative control, an extract from w1-
ovaries not containing mRFP1-fused proteins was treated identi-
cally. From the list of identified proteins all non-Drosophilid
proteins were removed, and then sorted according to the
cumulative intensities of the identified peptides. In both the ovary
and the embryo extracts, among the top eleven most abundant
Figure 3. Cap-G-EGFP co-localizes with HP1 in interphase and initiates chromatin loading at centromeres. (A) Cap-G is enriched at
heterochromatic regions during interphase. Living embryos co-expressing UAST-Cap-GFL-EGFP or UAST-Cap-GC-EGFP (green in merged panels) and
mRFP1-HP1 (red in merged panels) were analyzed while progressing through epidermal mitosis 14. Both EGFP-fused Cap-G-variants are locally
enriched within interphase nuclei and show a particular co-localization with mRFP1-HP1 (arrows). Cap-GFL-EGFP localizes to the chromatin in
metaphase (filled arrowhead) and anaphase cells (open arrowhead). (B) Cap-G loading initiates at centromeres. Embryos co-expressing gCap-GFL-EGFP
(green in merged panels) and Cid-mRFP (red in merged panels) were analyzed to determine the initial sites of Cap-GFL-EGFP loading while
progressing through post-blastodermal mitosis 14. Individual frames of a representative single nucleus are shown, with indicated times in min:sec
(t = 0, anaphase onset). Early Cap-GFL-EGFP accumulations frequently co-localize with Cid-mRFP1 signals (arrowheads). Scale bar 5 mm.
doi:10.1371/journal.pgen.1003463.g003
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Figure 4. Cap-G is not associated with condensin II–specific subunits in vivo. (A) Schematic model of a condensin complex with the
positions indicated that are recognized by antibodies used in the immunoprecipitation experiments. Fused EGFP or mCherry/mRFP tags are depicted
as green or red barrel-like structures, respectively. The red/green colored barrel fused to the N-terminus of Cap-H2 indicates that fusions with both
Functional Dissection of Drosophila Cap-G
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proteins, SMC2, SMC4, as well as the condensin-I specific
subunits Cap-H/Barren and Cap-D2 were identified (Figure 4B).
The majority of the peptides specific for SMC2 or SMC4 were
detected in gel slices containing proteins of molecular weights
corroborating our assignment of the SMCs in the silver stained IP-
eluates shown in Figure 2C. However, in the complete list of
identified proteins (189 for the embryonic extracts and 537 for the
ovary extract), neither Cap-D3 nor Cap-H2 were found, not even
represented by a single peptide (Tables S2 and S3). In a
complementary approach, we expressed EGFP- and mCherry-
fused variants of the condensin II-specific subunit Cap-H2 in
ovaries using the GAL4/UAS-system. These variants were shown
to be functional as they I) rescue the phenotypic consequences
described for Cap-H2 mutants in ovarian nurse cell nuclei and II)
trigger a dispersal of polytene chromatin when expressed in the
nuclei of larval salivary glands (Figure S9; [24]). Anti-EGFP-Cap-
H2 and anti-mCherry-Cap-H2 precipitates from ovarian extracts
were separated by SDS-PAGE, stained with colloidal Coomassie
Blue, and analyzed by MS (Figure 4C). Within the lists of
identified proteins, SMC2 and SMC4 can be found in both
experiments. However, the SMCs were ranked much lower in this
experiment when compared to the Cap-G immunoprecipitates,
indicating that they are of relatively low abundance in the Cap-
H2-specific precipitates. Significantly, within the complete list of
more than 1200 proteins in both cases, neither Cap-G nor Cap-
D3 could be found (Table S4). The N-terminal EGFP- and
mCherry-fusions in our Cap-H2 constructs may preclude efficient
complex formation. Therefore, we also performed immunopre-
cipitations of SMC2, from protein extracts of wild type or SMC2h-
EGFP expressing individuals, using either anti-SMC2-antibodies
or anti-EGFP antibodies, respectively. In these experiments, we
would expect to precipitate both condensin I and condensin II
complexes. Again, we could identify the components of the
condensin I complex in all cases, but in none of the three
experiments, the condensin II-specific components Cap-H2 or
Cap-D3 were detected (Figure 4D, Tables S5, S6, S7, S8).
As Cap-GFL is nuclear during interphase, like condensin II
subunits in other systems, one might expect condensin II-like
phenotypes in Cap-G mutant animals rescued by Cap-GNM, which
is cytoplasmic in interphase. A prominent phenotype in Drosoph-
ila Cap-D3 and Cap-H2 mutants is the perdurance of nurse cell
chromosome polyteny in developing egg chambers [24]. However,
in Cap-GNM rescued females, the nurse cell chromosomes disperse
on time, arguing against nuclear Cap-G fulfilling a condensin II-
like function (compare Figure S10A and S10B). We have
ascertained that in the rescue situation in this tissue, Cap-GNM
is also excluded from the nuclei (Figure S10C).
Taken together, the phenotypic analysis of nurse cell chromo-
somes in Cap-GNM rescued females, as well as our immunopre-
cipitation analyses argue against Cap-G being incorporated into a
soluble condensin II-like complex in Drosophila. Furthermore our
MS results also speak against the presence of soluble condensin II-
like complexes in the analyzed extracts in significant amounts.
Reconstitution of Drosophila condensin sub-complexes
in vitro
The analysis of condensin subunit associations described above
involved immunoprecipitations from complexes present in soluble
extracts from Drosophila tissues. To allow the assessment of direct
protein-protein interactions in a more simple system, we analyzed
complex formation of various condensin subunits produced in an
in vitro transcription/translation (IVT) system. In case the
molecular mass of the synthesized proteins was sufficiently
different, they were co-translated in the presence of [35S]methi-
onine, subjected to immunoprecipitation using antibodies against
fused epitope-tags, separated by SDS-PAGE, and detected by
autoradiography. Otherwise, proteins were translated in different
reactions only one of which contained [35S]methionine. After
mixing the extracts and subsequent immunoprecipitation, the
components were detected after SDS-PAGE both by autoradiog-
raphy and immunoblot.
To validate our system, we first wanted to demonstrate the
physical interactions between the condensin I-specific non-SMC
subunits. We used a C-terminally His-FLAG-epitope-tagged Cap-
H/Barren (Barren-HFHF) construct as bait. A C-terminally
extended Cap-H/Barren variant has been shown to be biologically
functional in the fly [28]. As a negative control, we prepared
human securin analogously tagged at its C-terminus with His-
FLAG (hSecurin-HFHF). Both Cap-G and Cap-D2 can be
specifically co-immunoprecipitated with Barren-HFHF, but not
with hSecurin-HFHF (Figure 5A). Thus, the Drosophila HEAT-
repeat containing condensin I subunits interact with the kleisin
subunit Cap-H/Barren like their human counterparts [35]. If
Cap-G is also part of condensin II, one would expect that it forms
a complex with the condensin II-specific kleisin subunit Cap-H2.
However, while Cap-G can be readily detected in immunopre-
cipitates of Barren-HFHF, it is not present in Cap-H2-HFHF
immunoprecipitates (Figure 5B). This result once more argues
against Cap-G being a condensin II component.
The human kleisin subunits were shown to interact with SMC4
[35]. Consistently, Drosophila SMC4 can be precipitated with
Barren-HFHF, in low amounts with Cap-H2-HFHF, but not with
hSecurin-HFHF (Figure 5C). This result reveals on the one hand a
reduced binding efficiency between Drosophila Cap-H2 and SMC4,
which is consistent with the results from our immunoprecipitation
analysis of ovarian extracts containing ectopically expressed Cap-
H2-variants (Figure 4C). On the other hand, it demonstrates that
in the IVT-system Cap-H2-HFHF is produced in a conformation
competent for complex formation, ruling out the possibility that
the lack of interaction between Cap-H2-HFHF and Cap-G is due
EGFP and mCherry were analyzed as shown in panel (C). Color coding of the antibodies (Y) corresponds to the color shading of the boxes with the
lists of identified proteins within the precipitates shown in panels (B–D). (B) Protein extracts from 3–6 h old embryos expressing gmRFP1-Cap-G as
well as from ovaries of wild type females (w1) or females expressing gmRFP1-Cap-G were subjected to immunoprecipitation with anti-mRFP
antibodies. Precipitated proteins were separated by SDS-PAGE and visualized by silver staining and in a parallel experiment with colloidal Coomassie
Blue. Coomassie Blue stained lanes were processed for mass spectrometric (MS) analysis. (C) Ovary extracts derived from females expressing UASP1-
mCherry-Cap-H2 or UASP1-EGFP-Cap-H2 driven by tubP-Gal4 were subjected to immunoprecipitation with anti-mRFP1 antibodies. Immunoprecip-
itates were separated by SDS-PAGE, stained with colloidal Coomassie Blue and processed for MS analysis. (D) Protein extracts from 3–6 h old embryos
expressing gSMC2h-EGFP (lane 1) or wild type embryos (lanes 2 and 3) as well as from ovaries of females expressing gSMC2h-EGFP (lane 4) were
subjected to immunoprecipitation using anti-EGFP antibodies (lanes 1 and 4), anti-SMC2-antibodies (lane2) or were mock treated with beads only
(lane 3). Immunoprecipitates were separated by SDS-PAGE, stained with colloidal Coomassie Blue (lanes 1–3) or a silver stain (lane 4) and processed
for MS analysis directly (lanes 1–3) or after a parallel SDS-PAGE subsequently stained with colloidal Coomassie (lane 4). In each case, the list of
identified Drosophila proteins was sorted according to the cumulative peptide intensities. The top ten ranked proteins, condensin subunits, and the
lowest ranked entries are listed.
doi:10.1371/journal.pgen.1003463.g004
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Figure 5. Reconstitution of Drosophila condensin sub-complexes in vitro. Drosophila condensin subunits and control proteins were
synthesized by coupled in vitro transcription/translation (IVT) either simultaneously in the presence of [35S]methionine (A, C) or in separate reactions
containing or lacking [35S]methionine (B, D, E, F). Hot and cold IVT reactions were mixed (B, D, E, F), or used directly (A, C), and were subjected to
immunoprecipitations using anti-Flag (A–C) or anti-myc (D–F) antibody-coated beads. The various combinations of synthesized proteins are indicated
by plus signs in the top parts of each panel. Proteins in samples of the input extracts (INPUT), supernatants after precipitation (SUP) and eluates from
the antibody-coated beads (IP) were separated by SDS-PAGE. The gels were either dried and directly subjected to autoradiography (AR in (A) and (C)),
or they were blotted onto nitrocellulose membranes and the proteins were detected by autoradiography (AR) or immunoblotting using anti-Flag (B)
or anti-myc (D–F) antibodies.
doi:10.1371/journal.pgen.1003463.g005
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to mis-folded Cap-H2-HFHF. Next we asked whether we could
reconstitute the condensin II-specific interaction between Cap-D3
and Cap-H2. To this end, we synthesized a Cap-D3 variant fused at
its N-terminus with six copies of the human c-myc-epitope (myc-
Cap-D3). In these experiments, we used as negative control the
catalytic (C)-subunit of human protein phosphatase 2A, also with an
N-terminal myc6-tag (myc-hPP2(A)C). Cap-H2 could be identified
in myc-Cap-D3 immunoprecipitates, but not in myc-hPP2(A)C
precipitates (Figure 5D). However, the co-precipitation efficiency
was again very low. Cap-H/Barren was also detected in myc-Cap-
D3 immunoprecipitates, but this protein was also precipitated by
myc-hPP2(A)C, arguing for non-specific associations. To under-
score the biological relevance of these in vitro studies, we attempted
to form ternary complexes. Based on the geometry of the human
condensin complexes, Cap-D2 does not directly interact with the
SMC subunits, but the kleisin subunit Cap-H/Barren is expected to
bridge Cap-D2 and SMC4. Indeed, SMC4 can be precipitated
together with myc-Cap-D2 when Cap-H/Barren is present, but not
in its absence (Figure 5E, compare lanes 9 and 11). When Cap-H2
was included in an analogous reaction instead of Cap-H/Barren,
Cap-H2 was precipitated with low efficiency, but SMC4 could not
be detected (Figure 5E, lane 10). In an effort to reconstitute an
analogous condensin II subcomplex, we precipitated myc-Cap-D3
in the presence of both Cap-H2 and SMC4 or just SMC4. In this
case, no ternary complex could be detected and only inefficient co-
precipitation of Cap-H2 with myc-Cap-D3was observed (Figure 5F,
lane 10). Cap-H/Barren did not co-precipitate with Cap-D3 above
background. Taken together, our in vitro complex forming studies
confirm the predicted interactions among theDrosophila condensin I-
specific subunits. However, the complex forming potential between
condensin II-specific subunits is limited and we find again no
evidence for incorporation of Cap-G in a condensin II-like
subcomplex.
Discussion
We set out to test the hypothesis that in Drosophila, Cap-G might
be part of both condensin I and condensin II. This hypothesis is
based on the facts that i) no condensin II-specific Cap-G2 homolog
can be identified in the Drosophila genome and ii) that SMC2 and
SMC4 are also part of both condensin complexes.
The localization pattern of Cap-G-EGFP in interphase initially
suggested its participation in a condensin II-like complex since it
was found to be nuclear like vertebrate condensin II subunits [9–
11]. At least, a functional importance was suggested by the
preferential nuclear localization of Cap-G and its different
dynamics in chromatin association when compared to the other
EGFP-fused condensin I subunits. However, the intriguing
observation that flies are viable and fertile, when they exclusively
express a C-terminal truncation variant of Cap-G, which is
nuclear excluded in interphase and gains access to chromatin only
around NEBD, suggests that its nuclear localization is dispensable
for proliferation and development, at least under laboratory
conditions. Furthermore, the observed heterochromatic enrich-
ment of Cap-G and its initiation of loading at the centromeric
regions are obviously not essential. It is possible that the Cap-G C-
terminus, which contains many predicted phosphorylation sites in
Drosophila and other organisms [36] may fine tune Cap-G activity.
This fine-tuning is probably required for the restoration of full
fertility in both sexes and early syncytial development, as shown by
the defects when no full length Cap-G is provided by the mother.
In this respect, the C-terminus might be required for full length
Cap-G to be sequestered into the nucleus to avoid any dominant
negative effects in the cytoplasm.
SMC2h-EGFP and EGFP-Cap-D2 localize like Cap-H/Barren-
EGFP [28] in the cytoplasm during interphase and rapidly
associate with chromatin during early stages of mitosis. Intrigu-
ingly, these subunits associate significantly later with chromatin
than Cap-G-EGFP, indicating that Cap-G has the potential to
bind to chromatin in the absence of the other condensin subunits.
This notion is supported by the observation that Cap-GC can
associate with chromatin in late anaphase, at a time point when
the other subunits dissociate. Recently, it has been shown in
human tissue culture cells and fission yeast that Cap-H binds to the
N-terminal tail of histone 2A and the variant histone 2A.Z. In vitro
studies have revealed that this binding can occur independent of
other condensin subunits [37]. While these results are consistent
with chromatin targeting of condensin via Cap-H in these systems,
our findings suggest that in Drosophila, Cap-G may direct
chromatin targeting of condensin. The target molecule on
chromatin, which is recognized by Drosophila Cap-G, remains to
be identified.
While our study is the first report on the dynamics of SMC2
localization in Drosophila during the cell cycle, our data on Cap-D2
appear to be at odds with studies on fixed S2 tissue culture cells
using anti-Cap-D2-antibodies [18]. In this study, Cap-D2 was
reported to be primarily nuclear. This discrepancy can be
explained by the different tissues analyzed. Nuclear import may
be slow for Cap-D2, as, in fact, Savvidou et al. [18] observe
increasing nuclear concentration of Cap-D2 when the cells
progress through G1-S-G2. During the rapid syncytial divisions,
nuclear import of Cap-D2 may not be efficient. Analysis of other
tissues of EGFP-Cap-D2 expressing animals indeed showed
nuclear localization, for example in ovarian follicle cells (data
not shown). Interestingly, nuclear localization of Cap-H2 has also
been described to progressively increase in more advanced ovarian
nurse cell nuclei when compared with nuclei at younger stages
[24], own unpublished observation).
Condensin complexes have been initially identified and
characterized in the biochemically tractable Xenopus egg extract
system [4]. In mitotic extracts, soluble 13S heteropentameric
holocomplexes as well as 8S SMC2/SMC4 dimers were readily
detected. Besides this initial identification of the complex later
termed condensin I, condensin II was also detected in high-speed
supernatants of Xenopus egg extracts [12], as well as in HeLa cell
lysates [12,38]. Quantification revealed that in the Xenopus egg
extract system condensin I is present in roughly five-fold excess
over condensin II while in HeLa cells both complexes occur in
approximately equimolar amounts [12]. These differences in
abundance are paralleled by a different appearance of condensed
chromosomes. While in HeLa cells, metaphase chromosomes
appear short and thick, the condensed chromosomes in the Xenopus
egg extract system are rather long and thin. Intriguingly,
experimentally shifting the ratio of condensin I:condensin II in
Xenopus egg extracts from ,5:1 to ,1:1 resulted in shorter and
thicker chromosomes [31]. As metaphase chromosomes in
Drosophila are also short and thick, one would expect a roughly
balanced abundance of the two condensin complexes, if condensin
I and II play comparable roles in the fly. As we did not detect any
soluble endogenous condensin II complexes in our immunopre-
cipitation analyses, this is apparently not the case. We have
analyzed extracts from ovaries and embryos. Cap-H2 mutants
display a phenotype in ovarian nurse cell nuclei suggesting that
Cap-H2 is expressed at this stage [24]. Also, the temporal
expression data provided by the modENCODE project reveal
expression of both Cap-H2 and Cap-D3 in ovaries and in early
embryos, albeit at only low to moderate levels [39]. In fact, these
levels are significantly lower than those reported for condensin I-
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specific subunits in most tissues indicating that condensin II-like
complexes must be of low abundance. Our analysis of ovarian
extracts derived from females overexpressing Cap-H2-fusion
proteins circumvented the issue of low endogenous expression
levels. Indeed, in these experiments, SMC2 and SMC4 were found
to be associated with overexpressed Cap-H2, but peptide
intensities and unique peptide numbers were significantly lower
than in the experiment, in which proteins in association with Cap-
G-mRFP1 in ovaries were assessed. Also, as our in vitro interaction
assays revealed only weak affinities of Cap-H2 towards Cap-D3
and SMC4 in solution, a condensin II-like holocomplex in
Drosophila may be functionally assembled in an efficient manner
only on chromatin, unlike the situation found in vertebrates.
Published studies on the phenotypic consequences of the loss of
Cap-D3 or Cap-H2 have shown that these phenotypes can be
modified by mutations in other condensin subunit genes (namely
Cap-H2, Cap-D3 and SMC4), thus revealing genetic interactions
[23,24,40]. However, it remains to be shown, whether these
genetic interactions are based on a physical interaction of these
subunits bound to the chromatin. Furthermore, such a chromatin-
associated condensin II-like holocomplex is unlikely to play a
mitotic role, given the absence of mitotic phenotypes in Cap-H2
and Cap-D3 mutants [18,23,24], which is also consistent with the
failure of EGFP-Cap-H2 to load onto mitotic chromatin (data not
shown).
Cap-G was not found in association with overexpressed Cap-
H2, even though Cap-G would be expected to bind to the kleisin
component if it was part of a condensin II-like complex [35]. The
direct binding assays of in vitro translated proteins also did not
produce any indication of an association of Cap-G with Cap-H2,
rendering the proposal of the participation of Cap-G in a
condensin II-like complex highly unlikely. So the question remains
whether a second HEAT-repeat containing protein besides Cap-
D3 is part of a putative condensin II complex in Drosophila. BLAST
analyses do not produce Cap-G2 homologs encoded in the D.
melanogaster genome or in any of the sequenced genomes of
dipterans. It is possible that a Cap-G2 homolog does exist in
Drosophila, but has escaped detection using the BLAST algorithms
because it might have diverged significantly during evolution.
Therefore, we have scrutinized the list of proteins identified in the
Cap-H2 immunoprecipitates for possible Cap-G2 candidates by
the virtue of a size above 100 kDa, and an extended stretch of
predicted HEAT repeats in the N-terminal region, but with
dissimilarity to importins/exportins which also have blocks of
HEAT repeats in their N-termini. However, none of the proteins
contained in the list of immunoprecipitated proteins qualifies as a
Cap-G2 homolog based on these criteria (data not shown). Thus,
the possibility remains that condensin II has diverged in dipterans
to function as a mainly chromatin-bound heterotetrameric
complex lacking a Cap-G2 subunit. Moreover, in combination
with the facts that Cap-H2 and Cap-D3 loss-of-function mutants
have no obvious mitotic phenotype [18,23] and that these two
subunits have been shown to participate in such diverse processes
as transvection, the regulation of AMP-expression or chromosome
territory formation [23–25,40], our results support a model in
which a Drosophila condensin II-like complex has functionally




Fly stocks were obtained from the Bloomington Drosophila Stock
Center at Indiana University, unless indicated otherwise. Expres-
sion constructs for condensin subunits were generated by cloning
genomic fragments isolated from bacterial artificial chromosomes
(BACs) obtained from CHORI BacPac Resources into appropri-
ate vectors, or cDNAs obtained from the Drosophila Genomic
Resource Center (DGRC) into the vectors pUAST or pUASP1
[14,41]. Appropriate restriction sites for cloning were introduced
by PCR with primers containing the recognition sequences for the
respective enzymes. The integrity of coding regions amplified by
PCR was verified by subsequent DNA sequence analysis.
Transgenic flies were generated by using established germ line
transformation protocols for microinjection into w1 embryos
(pUAST, pUASP1 and pBac-constructs) or into embryos express-
ing the PhiC31 integrase and containing an attP landing site at
specific genomic sites [42].
For the construction of fly stocks expressing an EGFP-fused
variant of SMC2, a 5.2 kb fragment containing SMC2 including its
flanking genomic regions was amplified from the BAC clone
CH321-59P12 as template and cloned into the pattB vector [42].
A 1370 bp internal PstI/MluI SMC2-fragment was subcloned into
the pSLfa1180fa vector [43] and fused with the EGFP-coding
sequence using a BspEI site introduced by inverse PCR. The
EGFP tag was fused internally between amino acid residues G582
and S583 of SMC2 within the hinge region (SMC2h-EGFP).
Internal fusions within the hinge region of yeast SMC1 and SMC3
have been shown to be functionally tolerated [44]. The modified
fragment was cloned back into the pattB-SMC2 vector. Trans-
genic flies were generated via injection of the pattB-SMC2h-EGFP
plasmid into y1, w1, M[vas-int]ZH2A; M[3x3P-RFP,attP9]ZH96E
embryos [42].
For the construction of fly stocks expressing an EGFP-fused
variant of Cap-D2 under control of the genomic regulatory
sequences, a 6.8 kb genomic fragment encompassing Cap-D2 and
600 bp upstream of the transcriptional start site as well as
1,600 bp downstream of the poly(A) site was cloned via
recombineering [45] into pattB using the BAC CH321-26K05
as sequence source. A 1.5 kb NotI/Acc65I fragment of the 59-
terminal Cap-D2 region was isolated from pattB-Cap-D2 and
subcloned into the pBluescriptSK vector (Stratagene). The
naturally occurring NcoI site at the Cap-D2 translational initiation
codon was used to insert a PCR-amplified fragment encoding
EGFP, flanked by PciI sites, which are compatible with NcoI. The
2.2 kb EGFP-fused NotI/Acc65I 59-terminal Cap-D2 fragment was
cloned back into the NotI/Acc65I cleaved pattB-Cap-D2. Trans-
genic flies were generated via injection of the pattB-EGFP-Cap-D2
plasmid into y1, w1, M[vas-int]ZH2A; M[3x3P-RFP,attP9]ZH22A
embryos [42].
For the construction of fly stocks expressing EGFP- and
mRFP1-fused variants of Cap-G under control of the genomic
regulatory sequences, a 1.2 kb XhoI fragment encompassing the 39-
terminal region of the Cap-G reading frame and downstream
regulatory sequences was cloned from a genomic Cap-G pBac
rescue construct [14] into the vector pLitmus 28 (New England
Biolabs). After introduction of a NotI restriction site immediately
upstream of the translational stop codon by inverse PCR, PCR-
amplified fragments encoding either EGFP or mRFP1 flanked by
NotI sites were cloned into this newly generated site. The modified
1.9 kb XhoI fragments were excised from the pLitmus 28
constructs and cloned back into the pBac Cap-G rescue constructs.
Transgenic flies were generated via injection of the pBac-Cap-G-
mRFP1 and pBac-Cap-G-EGFP plasmids into w1 embryos using
established procedures [43]. The genomic region encoding Cap-
G-EGFP was also cloned into the pattB vector and transgenic lines
were established after injection into y1, w1, M[vas-int]ZH2A;
M[3x3P-RFP,attP9]ZH96E embryos.
Functional Dissection of Drosophila Cap-G
PLOS Genetics | www.plosgenetics.org 12 April 2013 | Volume 9 | Issue 4 | e1003463
For the construction of pUAST-Cap-G-EGFP vectors containing
various Cap-G fragments, the corresponding Cap-G coding regions
were PCR-amplified from the cDNA clone SD10043 and cloned
into pUAST-MCS-EGFP [46]. Fragments encoding the following
Cap-G-variants were amplified: Cap-GFL (full length, aa 1–1351);
Cap-GNM (aa 1- 977); Cap-GNM1 (aa 1–848); Cap-GNM4 (aa 243-
977); Cap-GC (aa 958–1351). For the construction of pUASP1-Cap-
GNM-EGFP, the Cap-GNM-EGFP-fragment was transferred from
pUAST-Cap-GNM-EGFP into pUASP1 [14]. The constructs were
used for P-element-mediated germ line transformation by injection
into w1 embryos following established procedures. For all
experiments, the following established lines were used: UAST-
Cap-GFL-EGFP II.2, UAST-Cap-GFL-EGFP III.2, UAST-Cap-GNM-
EGFP III.2, UAST-Cap-GC-EGFP II.3, UAST- Cap-GC -EGFP III.2,
UAST-Cap-GNM1-EGFP II.1, UAST-Cap-GNM4-EGFP II.1, UASP1-
Cap-GNM-EGFP III.4, UASP1-Cap-GNM III.2. Cap-GNM –EGFP and
Cap-GNM were also cloned into the pattB vector containing the
flanking Cap-G genomic regulatory elements ensuring expression
at physiological levels. Transgenic lines were established after
injection into y1, w1, M[vas-int]ZH2A; M[3x3P-RFP,attP9]ZH96E
embryos.
For the construction of pUASP1-EGFP-Cap-H2 and pUASP1-
mCherry-Cap-H2, the Cap-H2 coding region (based on the Cap-H2-
RE annotation) was isolated using NcoI/XhoI from the cDNA clone
SD18322 and subcloned into pLitmus28. The resulting plasmid
pLitmus28-Cap-H2 was cleaved with AvrII/NcoI and PCR-
fragments encoding mCherry and EGFP were inserted as AvrII/
PagI fragments. The EGFP-Cap-H2 and mCherry-Cap-H2 cassettes
were finally transferred as SpeI/Asp718-fragments into pUASP1 to
generate pUASP1-EGFP-Cap-H2 and pUASP1-mCherry-Cap-H2,
respectively, which were used for P-element-mediated germ line
transformation. For all experiments, the transgene insertions
UASP1-EGFP-Cap-H2 II.4 and UASP1-mCherry-Cap-H2 II.1 were
used.
For expression of UAS-transgenes, we used da-GAL4 G32 [47],
F4-GAL4 [48], maternal a4tub-GAL4-VP16 [49] and tubP-GAL4.
Rescue experiments were performed using trans-heterozygous
mutant allele combinations of the respective genes, simultaneously
expressing our transgenes either under control of the flanking
genomic regulatory regions or under UAS-control driven by the
ubiquitous active GAL4-driver da-GAL4 G32 or by a4tub-GAL4-
VP16 in the case of Cap-H2. The following alleles were used: Cap-
G1 and Cap-G6 [14], Cap-D2f03381, Cap-D2 Df(3R)01215, SMC2jsl2,
SMC2f06842, SMC2Df(2R)BSC429, Cap-H2Df(3R)Exel6159 , Cap-H2EY09979
and Cap-H2TH2 [24]. For Cap-G, Cap-D2 and SMC2, complemen-
tation of the lethality associated with the trans-heterozygous mutant
situation was assessed. For Cap-G, rescued trans-heterozygous
individuals could be readily identified by the recessive markers al,
b, c and sp present on the Cap-G1 and Cap-G6 chromosomes [14].
For Cap-H2, suppression of the delayed dispersal of nurse cell
chromatin observed in Cap-H2 mutant ovarioles [24] was
monitored upon transgene expression. Furthermore, the pheno-
type upon overexpression of EGFP-Cap-H2 and mCherry-Cap-H2 in
larval salivary glands was compared with the phenotype obtained
after the GAL4 dependent Cap-H2 overexpression using the allele
Cap-H2EY09979, which is an UAS containing P-element inserted
upstream of Cap-H2.
To drive expression of Cap-GNM1-EGFP or Cap-GNM4-EGFP
together with His2Av-mRFP1, individuals of the corresponding
UAS-lines were crossed with w*, a-tub-GAL4-VP16, gHis2Av-
mRFP1 II.2 flies (generously provided by C. Lehner, University
of Zurich).
To express HP1-mRFP1 together with Cap-GFL-EGFP or Cap-
GC-EGFP, we generated recombinant chromosomes containing
either UAST-Cap-GFL-EGFP II.2 or UAST-Cap-GC-EGFP II.3
together with gmRFP1-HP1 II.1 [50] using standard genetic
techniques.
To co-express Cap-GFL-EGFP with Cid-mRFP1, both under
control of the flanking genomic sequences, lines were generated by
classical genetic techniques containing the gCap-GFL-EGFP III.1
and gCid-mRFPII.1 [28] transgenes.
For chromatin loading analyses, chromosomes carrying a
transgene allowing expression of His2Av fused with mRFP1 [51]




Antibodies against the human c-myc epitope [52], Drosophila
Cap-H/Barren [22] and Drosophila Cap-D2 [18] have been
described previously.
Rabbit-anti-Flag (Sigma), mouse-anti a-Tubulin (Sigma) as well
as secondary antibodies (Jackson laboratories) were obtained
commercially. Antibodies against EGFP and mRFP1 were raised
in rabbits using bacterially expressed full length proteins as
antigen. The anti-mRFP1 antibodies also recognize and precip-
itate mCherry-fused proteins. Mouse monoclonal antibodies
against EGFP were purchased from Roche Biochemicals or were
a gift from D. van Essen and S. Saccani (MPI Freiburg, Germany).
Antibodies against Cap-G and SMC2 were raised in rabbits
using bacterially expressed N-terminal protein fragments of Cap-G
(aa 1- 553) and SMC2 (aa 1–313), respectively. The antisera were
affinity purified using standard procedures [53]. For immunoblot-
ting, the antibodies were used at a 1:3000 dilution. A mouse
monoclonal antibody directed against HP1 was obtained from the
Developmental Studies Hybridoma Bank (clone C1A9; dilution
1:1000 for immunoblotting).
Microscopy and image processing
For in vivo microscopy, embryos at the desired developmental
stage were collected and processed as previously described [54].
Single-stack confocal images were acquired every 18 or 20 sec
using a Leica SP5 confocal microscope (Leica Microsystems,
Germany), equipped with a 636 oil-immersion objective, a 458–
514 nm Ar laser and a 561 nm DPSS laser for the excitation of
EGFP and mRFP1, respectively. For fixed samples stained with
Hoechst 33258, a 405 nm UV- diode laser was used in addition,
and confocal images were acquired with a 406 oil-immersion
objective.
Images were processed using ImageJ 1.46 (National Institute of
Health, USA) and Adobe Photoshop CS4 (Adobe Systems Inc.). In
some images, shot noise was decreased with a Gaussian filter.
Quantitative fluorescence measurements to determine chroma-
tin association of the EGFP-fused condensin subunits was done as
described in [28] with the exception that a Leica SP5 confocal
system was used for analysis of EGFP-Cap-D2 and SMC2h-EGFP.
The analyzed genotypes were gCap-G-EGFP III.1, gHis2Av-mRFP1
III.1/TM3, Ser or gHis2Av-mRFP1 II.2; gSMC2h-EGFP
WX-96E or
gCap-D2-EGFPWX-22A; gHis2Av-mRFP1 III.1. or SMC2f06842/
SMC2Df(2R)BSC429; gSMC2h-EGFP
WX-96E .To quantify Cap-G-
EGFP in centromeric regions, embryos co-expressing Cap-G-EGFP
and Cid-mRFP were analyzed by laser scanning time lapse
microscopy while progressing through the syncytial cycle 12.
Small circular regions of interest (R.O.I.s) were defined in the
channel for Cid-mRFP fluorescence, one encircling a centromere
(cen-proximal) and one of the same size in a region within the
nucleus but not encircling a centromere. The identical R.O.I.s
were applied to the channel for Cap-G-EGFP fluorescence and the
ratio of the cen-proximal fluorescence intensity:cen-distal
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fluorescence intensity was calculated. For each time point, 62 pairs
of R.O.I.s from three different embryos were evaluated.
Immunoblotting and immunoprecipitation experiments
For immunoblotting experiments, ovaries of 4–5 days old
females were dissected in 16 PBS and homogenized in sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
sample buffer. Protein samples corresponding to 5 ovaries were
loaded on Tris-glycine based polyacrylamide gels and blotted onto
nitrocellulose membranes.
For the immunoprecipitation experiments, 5–8 h old embryos
expressing fluorescently tagged Cap-G variants were collected on
apple-juice agar plates and dechorionized. Alternatively, we
dissected ovaries in 16PBS from females expressing epitope-
tagged condensin subunits. These tissues (150 ml embryos or 300
ovaries) were homogenized in 4 volumes of lysis buffer (50 mM
HEPES at pH 7.5, 60 mM NaCl, 3 mM MgCl2, 1 mM CaCl2,
0.2% Triton X-100, 0.2% Nonidet NP-40, 10% glycerol)
including protease inhibitors (2 mM Pefabloc, 2 mM Benzamidin,
10 mg/ml Aprotinin, 2 mg/ml Pepstatin, A, 10 mg/ml Leupeptin).
In the experiment shown in Figure S6, aliquots of the raw extracts
were treated with a mixture of DNaseI and nuclease S7 for 45 min
at 4uC to solubilize chromatin. The extracts were cleared by
centrifugation (20 min, 140006g; 4uC) and 200–400 ml of the
supernatants were used for immunoprecipitation with anti-EGFP-,
anti-mRFP1-, or anti-SMC2-antibodies bound and covalently
cross-linked using dimethyl pimelimidate to Protein A-Sepharose
(Affi-Prep Protein A, BIORAD; 25 mg of affinity purified
antibodies bound to 30 ml of Protein A-Sepharose slurry). In the
experiment shown in Figure S6, mouse monoclonal antibodies
(Roche) were coupled to Protein G-Sepharose (GE Healthcare).
After 3–4 h incubation at 4uC with gentle agitation, the Sepharose
was washed for four times with 1 ml of lysis buffer. Bound
polypeptides were eluted by incubation with 40 ml of elution buffer
(50 mM Tris/HCl at pH 6.8; 2% (w/v) SDS) for 10 min at 37uC
and/or by addition of 40 ml SDS-PAGE sample buffer and
subsequent incubation at 95uC for 5 min (‘‘hot elution’’).
The immunoprecipitates were subjected to SDS–PAGE fol-
lowed by silver staining (‘‘PageSilver Silver Staining Kit’’,
Fermentas) or by western blot analysis.
Mass spectrometric analysis
For mass spectrometric analysis, immunoprecipitates were
separated by SDS-PAGE on precast gradient gels (Serva,
Heidelberg) and the proteins were visualized by staining with
colloidal Coomassie Blue according to [55]. Entire gel lanes
containing immunoprecipitates were cut into slices. Proteins were
extracted from the gel pieces, digested with trypsin, separated via
on-line nanoLC and analyzed by electrospray tandem mass
spectrometry at an LTQ Orbitrap mass spectrometer. The
complete lists with the identified proteins are available in the
supplementary information.
In vitro transcription/translation reactions
DNA fragments encoding different regions of the condensin
subunits were amplified by PCR and inserted into the vectors
pCS2(F/A), pCS2(F/A)-HFHF (allowing a fusion of a C-terminal
His6 Flag His6 Flag epitope tag), and/or pCS2-myc6(F/A) (allowing
a fusion of an N-terminal myc6-epitope tag) , which all contain
FseI/AscI-restriction sites within their MCS. Condensin coding
regions were amplified from the cDNA clones SD10043 (Cap-G),
LD40412 (Cap-D2), RE48802 (Cap-H/Barren), SD18322 (Cap-
H2, based on the Cap-H2-RE annotation) and RE74832 (Cap-D3,
based on the Cap-D3-RA annotation).
To generate pCS2-Cap-G-EGFP, the Cap-G-EGFP fragment was
transferred fromUAST-Cap-GFL-EGFP into pCS2(F/A). To generate
pCS2-SMC4, the corresponding coding region was amplified using
first strand cDNA derived from reverse transcription of mRNA
extracted from w1-embryos, using the ‘‘RNeasy Mini Kit’’ and the
‘‘Omniscript RT Kit’’ (Qiagen), and inserted into pCS2(F/A).
For controls, the plasmids pCS2-hSecurin-HFHF and pCS2-myc6-
hPP2A(C) (generously provided by O. Stemmann) were used,
which contain the coding DNA sequences for human securin and
the catalytic subunit of the human protein phosphatase 2A,
respectively.
Coupled in vitro transcription/translation reactions (IVT) were
performed using the ‘‘TNT SP6 Coupled Reticulocyte Lysate
System’’ or the ‘‘TNT SP6 Quick Coupled Transcription/
Translation System’’ (Promega) according to the manufacturer’s
instructions. Up to 3 different plasmids (final amount of 2 mg DNA
total) were included in 25 ml reaction mixtures. For radioactive
labeling, 0.4 mM [35S]methionine (1000 Ci/mmol) was added to
the reaction mix. In some instances, the produced proteins
migrated at almost the same position during SDS-PAGE. In these
cases, only the components without an epitope tag were translated
in the presence of [35S]methionine. The epitope tagged variants
were translated in a separate reaction in the absence of radioactive
label. Afterwards, the reactions were mixed and subjected to
immunoprecipitation using 5 ml of mouse-anti-Flag-Agarose-slurry
(Sigma, A1080) or 5 ml Protein-A-Sepharose beads to which
monoclonal mouse antibodies against the myc-epitope had been
covalently crosslinked with dimethyl pimelimidate [53]. After 3 h
incubation at 4uC with gentle agitation and a subsequent brief
centrifugation, the supernatants were removed and immunopre-
cipitates were washed 3 times with 1 ml of lysis buffer. Bound
polypeptides were eluted by addition of 40 ml SDS-PAGE sample
buffer and subsequent incubation at 95uC for 5 min. Precipitated
polypeptides as well as samples derived from the input and
supernatant fractions were resolved by SDS-PAGE and analyzed
by immunoblotting and/or autoradiography (FLA 7000 Phos-
phoimager, Fuji Corp.)
Supporting Information
Figure S1 Construction and expression of EGFP-fused con-
densin variants. (A) Schematic presentation of all constructs, which
are based on genomic DNA sequences. Orange bars represent the
condensin reading frames including introns and the green bars the
fused EGFP reading frame. Light grey bars indicate 59- and 39-
UTRs. Dark grey bars represent 59- and 39-flanking genomic
regions. While Cap-G and Cap-D2 were tagged at their C-
terminus and N-terminus, respectively, the EGFP reading frame
was inserted into SMC2 between the codons for amino acids
glycine 582 and serine 583. (B) Analysis of expression levels.
Extracts were prepared from 0–3 hrs old embryos derived from
mothers carrying one transgene copy and which had been mated
with wild type (w1) males. Proteins contained in four serial
dilutions of each extract were separated by SDS-PAGE, blotted,
and detected with monoclonal anti-EGFP antibodies (aEGFP) and
anti-a-tubulin antibodies (atubulin) as loading control.
(TIF)
Figure S2 Dynamics of chromatin association of SMC2h-EGFP
in an SMC2 mutant background. (A) The fluorescence intensity of
SMC2h-EGFP in syncytial embryos laid by mothers with the
genotype SMC2f06842/SMC2Df(2R)BSC429; gSMC2h-EGFP
WX-96E was
determined for selected nuclei progressing through mitosis 12 in
each frame, and is plotted as relative intensity per nucleus (green
curve, SMC2 rescue). As these embryos did not contain the red
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fluorescent His2Av-mRFP1, a correction for chromatin compac-
tion (as done in Figure 1B) was not possible. Thus, the data for
SMC2h-EGFP in a SMC2
+-background was processed analogously
(red curve, SMC2 (w/o HismRFP)). Data series were aligned
accordingly to anaphase onset (t0 = last metaphase frame). Data
sets from a total of 28 nuclei from 12 embryos were aligned. The
curves for Cap-D2, Cap-H/Barren, Cap-G, and SMC2 are the
same as in Figure 1B and are shown for reference. The times of
initiation of chromatin condensation (ICC) and NEBD are
indicated by the dotted and dashed red lines, respectively. (B)
Western blot analysis of extracts from 0–3 hrs old embryos with
the genotype y1, M{vas-int.Dm}ZH-2A, w*; M{3xP3-RFP.attP9}ZH-
96E (WX 96E) or laid by mothers with the genotype SMC2f06842/
SMC2Df(2R)BSC429; gSMC2h-EGFP
WX-96E (SMC2 rescue). The blot
was probed with anti-SMC2 antibodies (upper panel) and anti-a-
tubulin antibodies as loading control (bottom panel).
(TIF)
Figure S3 Time-lapse analysis of Cap-GNM-EGFP association
with chromatin. Subcellular localization and chromatin associa-
tion of Cap-GNM-EGFP observed in a living embryo progressing
through epidermal mitosis 14. Expression of the UAST-Cap-GNM-
EGFP transgene was driven by a4-tub-GAL4-VP16. NEBD occurs
between time points24:00 and23:40 as indicated by the influx of
Cap-GNM-EGFP into the nuclear space. Chromatin enrichment of
Cap-GNM-EGFP is detectable starting from time point -3:20.
Individual frames of time lapse movies are shown with time points
indicated in min:sec (t = 0, anaphase onset). In the merged panels,
His2Av-mRFP and Cap-GNM-EGFP are shown in red and green,
respectively. Scale bar is 5 mm.
(TIF)
Figure S4 Western blot analysis of proteins associated with Cap-
G fragments. Extracts from 3–6 h old embryos expressing various
EGFP-fused Cap-G-fragments driven by a4-tub-GAL4-VP16 were
subjected to immunoprecipitation with rabbit-anti-EGFP antibod-
ies. Bound proteins were eluted in two steps with increasing
stringency. Precipitates were separated by SDS-PAGE and blotted
onto a nitrocellulose membrane. The blot was probed with
antibodies against Cap-D2 (top panel), against Cap-H/Barren
(middle panel) and against EGFP (lower panel). Cap-D2 and Cap-
H/Barren were efficiently precipitated by Cap-GFL-EGFP (FL)
and Cap-GNM-EGFP (NM) and were eluted during the first step
(IP 1st elution), while they were much less efficiently precipitated
by Cap-GNM4-EGFP (NM4) and Cap-GC-EGFP (C). The second
elution step (IP 2nd elution) mainly reveals the recovery of the
EGFP-fused Cap-G-fragments (indicated by arrowheads). Note
that Cap-GNM4-EGFP and Cap-GC-EGFP migrate at the same
position in the SDS-polyacrylamide gel. Asterisks indicate proteins
cross-reacting with the anti-EGFP antibody.
(TIF)
Figure S5 Subcellular localization of Cap-GNM1-EGFP and
Cap-GNM4-EGFP. Living embryos expressing His2Av-mRFP1 and
Cap-GNM1-EGFP (A) or Cap-GNM4-EGFP (B) were observed while
progressing through epidermal mitosis 14. Individual frames of
time lapse movies are shown with time points indicated in min:sec.
The top rows show the distribution of the EGFP-fused Cap-G
fragments and the bottom rows of His2Av-mRFP1. Red triangles
highlight individual cells progressing through mitosis. Scale bar is
5 mm.
(TIF)
Figure S6 HP1 does not co-precipitate with Cap-G. Extracts of
4–7 hrs old embryos expressing UAS-Cap-GFL-EGFP or UAS-Cap-
GC-EGFP driven by da-GAL4 were either treated (+) or not treated
(2) with nuclease to solubilize chromatin. After centrifugation to
pellet debris and undigested chromatin, the supernatant was used
for immunoprecipitation with monoclonal anti-EGFP antibodies.
Proteins in the raw extracts, the cleared supernatants (INPUT) and
the eluates after immunoprecipitation (ELUATE IP aEGFP) were
separated by SDS-PAGE, blotted, and detected using a different
anti-EGFP antibody, anti-SMC2, and anti-HP1 antibodies.
Asterisks denote cross-reactions of the HP1-antibody. HP1 is not
detectable in the IP eluates, while SMC2 is readily and specifically
co-precipitated with Cap-GFL. Note that in the INPUT samples
treated with nuclease, the abundance of HP1 is increased when
compared with the samples without nuclease treatment, indicating
successful chromatin solubilization.
(TIF)
Figure S7 Quantitative measurement of Cap-G-EGFP accumu-
lation at centromeric regions. Embryos co-expressing Cap-GFL-
EGFP and Cid-mRFP1 were observed while progressing through
syncytial mitosis 12. (A) Graphic representation of the ratios
between mean Cap-G-EGFP fluorescence intensity of centromere
proximal regions (MFI cen-proximal) and the mean Cap-G-EGFP
fluorescence intensity of centromere distal regions (MFI cen-distal)
plotted over time. t = 0 min corresponds to anaphase onset. n = 62
for each time point. ICC (initiation of chromosome condensation)
and NEBD (nuclear envelope breakdown) time points are adapted
from the experiment shown in Figure 1. (B) Example of images
illustrating the selection of R.O.I.s for the quantitative fluores-
cence measurements.
(TIF)
Figure S8 Cap-G mutant animals rescued by Cap-GNM-EGFP:
Lack of endogenous Cap-G expression and failure of Cap-GNM-
EGFP to localize to prophase chromatin. (A) Extracts were
prepared from ovaries from animals expressing wild type Cap-G
(w1, lane 1) or the C-terminally truncated variant Cap-GNM-EGFP
in a Cap-G1/Cap-G6 trans-heterozygous mutant background (lanes
2 and 3) under control of the ubiquitous driver da-GAL4. The
transgenes were contained either in the vector pUAST (lane 2) or
in the vector pUASP1 (lane 3). Extracts corresponding to 5 ovaries
were separated on an SDS-polyacrylamide gel, blotted onto a
nitrocellulose membrane and the blot was probed with anti-Cap-G
antibodies recognizing the N-terminus of the protein (anti-Cap-
G(N)) or as a loading control with anti-tubulin antibodies. Note
that full-length Cap-G is partially degraded in lane 1. (B) Embryos
derived from mothers with the genotype Cap-G1/Cap-G6; da-
GAL4/UASP1-Cap-GNM-EGFP III.4 were fixed and treated with
Hoechst 33258 to stain the DNA. In the left panel, nuclei in the
periphery of an embryo are shown progressing through prophase
of syncytial mitosis 13. The right panel shows epidermal nuclei of
an embryo progressing through mitosis 14. Cells in prophase (Pro),
metaphase (Meta) and anaphase (Ana) are indicated by yellow
arrowheads. Prophase cells were identified by the appearance of
condensed chromatin. Note the failure of Cap-GNM-EGFP to
localize to prophase chromatin, while it is readily detected on
metaphase and anaphase chromatin. Scale bar is 20 mm.
(TIF)
Figure S9 Functionality of Cap-H2 transgenes. UASP1-EGFP-
Cap-H2 and UASP1-mCherry-Cap-H2 were expressed in stage 10
egg chambers using the mat atub-GAL4 driver (C, D, c, d) or in 3rd
instar salivary glands using the F4-GAL4 driver line (G, g, H, h).
Cap-H2 mutants retain the polytene chromosome morphology of
nurse cell nuclei in stage 10 egg chambers which is normally lost in
mid-oogenesis [24](Compare B, b with A, a). Expression of the
Cap-H2 transgenes at least partially restores the dispersal of the
chromosomes when expressed in the Cap-H2 mutant background
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(C, c, D, d). Conversely, Cap-H2 overexpression results in the
dispersal of the polytene salivary gland nuclei chromosomes
(compare F, f with E, e). Likewise, ectopic expression of EGFP-Cap-
H2 (G,g) or mCherry-Cap-H2 (H, h) results in the dispersal of the
polytene salivary gland nuclei chromosomes. The Cap-H2 alleles
used were Cap-H2Df(3R)Exel6159 (Exel6159), Cap-H2EY09979
(EY09979), and Cap-H2TH2 (TH2). (a–h) show representative,
enlarged single nuclei from (A–H), respectively. Scale bars in A–D,
E–H, and a–h are 20 mm, 50 mm, and 5 mm, respectively.
(TIF)
Figure S10 Absence of condensin II-like phenotypes in egg
chambers of Cap-GNM rescued females. Ovaries were prepared
from Cap-D3EY00456 homozygous females (A) and from Cap-G
trans-heterozygous mutant females expressing Cap-GNM (Cap-G1/
Cap-G6; Cap-GNM) or from sibling females (Cap-G1/CyO; Cap-GNM)
(B). DNA was stained with Hoechst 33258 and the polytenic state
of the nurse cell chromosomes was analyzed. Overviews of typical
stage 6 and stage 10 egg chambers are shown in the left panels,
while representative nurse cell nuclei for stage 6 and stage 10 egg
chambers are shown in the right panels. Note the more condensed,
polytene-like appearance of the nurse cell chromosomes in Cap-D3
mutant egg chambers, while chromatin is more dispersed in egg
chambers of Cap-GNM rescued and control females. (C) Stage 10
egg chambers from Cap-G mutant females rescued by da-Gal4
driven expression of UASP1-Cap-GNM-EGFP (upper panel) or from
individuals expressing Cap-GFL-EGFP in a wild-type background
(lower panel). Ovarioles were fixed, treated with Hoechst 33258 to
stain DNA, and the localization of the transgene products was
assessed by observing EGFP autofluorescence. Note that Cap-
GNM-EGFP is excluded from the nuclei and is enriched in the
cytoplasm, while Cap-GFL-EGFP co-localizes with nurse cell and
follicle cell chromatin. In the merged panels, DNA is shown in red
and EGFP autofluorescence in green. Scale bar units are in mm.
(TIF)
Table S1 Results of rescue experiments using various Cap-GFL
and Cap-GNM transgene insertions. All rescued individuals were
trans-heterozygous for the alleles Cap-G1 and Cap-G6. UAS
transgenes were expressed using the ubiquitous driver da-GAL4.
The genomic transgenes were all pattB-constructs inserted at 96E.
Crosses were kept at 22uC to 24uC. n.d. - not determined. 1) only
very vew progeny were obtained from this cross. It was not
possible to establish a rescue stock. 2) Rescued females gave rise to
only very few progeny. 3) Only females rescued by one transgene
copy were obtained in these crosses.
(DOCX)
Table S2 Complete list of proteins identified in anti-mRFP1
immunoprecipitates from ovary extracts of Cap-G-mRFP1 express-
ing females. Condensin subunits are highlighted in light grey. The
hits are ranked according to their cumulated peptide intensities in
the Cap-G-mRFP1 sample. Included are the peptide intensities of
the same proteins detected in precipitates from w1-ovaries not
expressing Cap-G-mRFP1.
(XLSX)
Table S3 Complete list of proteins identified in anti-mRFP1
immunoprecipitates from embryo extracts of Cap-G-mRFP1
individuals. Condensin subunits are highlighted in light grey.
The hits are ranked according to their cumulated peptide
intensities.
(XLSX)
Table S4 Complete list of proteins identified in anti-mRFP1 and
anti-EGFP immunoprecipitates from ovary extracts of females
expressing mCherry-Cap-H2 or EGFP-Cap-H2, respectively. Con-
densin subunits are highlighted in light grey. The hits are ranked
according to their cumulated peptide intensities.
(XLSX)
Table S5 Complete list of proteins identified in anti-EGFP
immunoprecipitates from embryo extracts of SMC2h-EGFP
expressing individuals. Condensin subunits are highlighted in
light grey. The hits are ranked according to their cumulated
peptide intensities.
(XLSX)
Table S6 Complete list of proteins identified in anti-SMC2
immunoprecipitates from w1 embryo extracts. Condensin subunits
are highlighted in light grey. The hits are ranked according to their
cumulated peptide intensities.
(XLSX)
Table S7 Complete list of proteins identified in anti-EGFP
immunoprecipitates from ovary extracts of SMC2h-EGFP express-
ing females. Condensin subunits are highlighted in light grey. The
hits are ranked according to their cumulated peptide intensities.
(XLSX)
Table S8 Complete list of proteins identified in mock immuno-
precipitates from w1-embryos. The hits are ranked according to
their cumulated peptide intensities.
(XLSX)
Video S1 Embryo co-expressing EGFP-Cap-D2 and His2Av-
mRFP1 progressing through mitosis 12. The left panel shows
EGFP fluorescence only and the right panel the merge of the
EGFP and mRFP1 channels. Time stamp is in min:sec.
(MOV)
Video S2 Embryo co-expressing SMC2h-EGFP and His2Av-
mRFP1 progressing through mitosis 12. The left panel shows
EGFP fluorescence only and the right panel the merge of the
EGFP and mRFP1 channels. Time stamp is in min:sec.
(MOV)
Video S3 Embryo co-expressing Cap-GFL-EGFP and His2Av-
mRFP1 progressing through mitosis 12. The left panel shows
EGFP fluorescence only and the right panel the merge of the
EGFP and mRFP1 channels. Time stamp is in min:sec.
(MOV)
Video S4 Embryo expressing Cap-GC-EGFP progressing
through mitosis 14. Time stamp is in min:sec.
(MOV)
Video S5 Embryo co-expressing Cap-GNM-EGFP and His2Av-
mRFP1 progressing through mitosis 14. The left panel shows
EGFP fluorescence only and the right panel the merge of the
EGFP and mRFP1 channels. Time stamp is in min:sec.
(MOV)
Acknowledgments
We thank Brigitte Jaunich and Katharina Trunzer for technical support,
Joe Lipsick and Christian Lehner for fly stocks, Margarete Heck for anti-
Cap-D2 antibodies, Simona Saccani and Dominic van Essen for
monoclonal anti-EGFP antibodies, Frank Schnorrer and Gunter Meister
for help with MS analysis, and Olaf Stemmann for generous support and
plasmids used in the IVT experiments. We are indebted to Raquel
Oliveira, Johannes Reithinger, Martina Frank, Regine Ha¨fner, and
Kristina Seel for help in establishing Cap-G-mRFP1 transgenic lines,
generating anti-Cap-G antibodies, initial characterization of transgenes,
construction of plasmids for the IVT experiments, and analysis of SMC2
rescue stocks, respectively. We also thank members of the lab for helpful
discussions and Olaf Stemmann for generous support and critical reading
of the manuscript.
Functional Dissection of Drosophila Cap-G
PLOS Genetics | www.plosgenetics.org 16 April 2013 | Volume 9 | Issue 4 | e1003463
Author Contributions
Conceived and designed the experiments: SKH SH. Performed the
experiments: SH SNJ EU AR SF SKH. Analyzed the data: SKH SH SNJ
EU AR SF. Wrote the paper: SKH SH.
References
1. Wood AJ, Severson AF, Meyer BJ (2010) Condensin and cohesin complexity:
the expanding repertoire of functions. Nat Rev Genet 11: 391–404.
2. Hudson DF, Marshall KM, Earnshaw WC (2009) Condensin: Architect of
mitotic chromosomes. Chromosome Res 17: 131–144.
3. Hirano T (2012) Condensins: universal organizers of chromosomes with diverse
functions. Genes Dev 26: 1659–1678.
4. Hirano T, Kobayashi R, Hirano M (1997) Condensins, chromosome
condensation protein complexes containing XCAP-C, XCAP-E and a Xenopus
homolog of the Drosophila Barren protein. Cell 89: 511–521.
5. Hirano T, Mitchison TJ (1994) A heterodimeric coiled-coil protein required for
mitotic chromosome condensation in vitro. Cell 79: 449–458.
6. Schleiffer A, Kaitna S, Maurer-Stroh S, Glotzer M, Nasmyth K, et al. (2003)
Kleisins: a superfamily of bacterial and eukaryotic SMC protein partners. Mol
Cell 11: 571–575.
7. Andrade MA, Perez-Iratxeta C, Ponting CP (2001) Protein repeats: structures,
functions, and evolution. J Struct Biol 134: 117–131.
8. Green LC, Kalitsis P, Chang TM, Cipetic M, Kim JH, et al. (2012) Contrasting
roles of condensin I and condensin II in mitotic chromosome formation. J Cell
Sci 125: 1591–1604.
9. Gerlich D, Hirota T, Koch B, Peters JM, Ellenberg J (2006) Condensin I
stabilizes chromosomes mechanically through a dynamic interaction in live cells.
Curr Biol 16: 333–344.
10. Hirota T, Gerlich D, Koch B, Ellenberg J, Peters JM (2004) Distinct functions of
condensin I and II in mitotic chromosome assembly. J Cell Sci 117: 6435–6445.
11. Ono T, Fang Y, Spector DL, Hirano T (2004) Spatial and temporal regulation
of Condensins I and II in mitotic chromosome assembly in human cells. Mol
Biol Cell 15: 3296–3308.
12. Ono T, Losada A, Hirano M, Myers MP, Neuwald AF, et al. (2003) Differential
contributions of condensin I and condensin II to mitotic chromosome
architecture in vertebrate cells. Cell 115: 109–121.
13. Csankovszki G, Collette K, Spahl K, Carey J, Snyder M, et al. (2009) Three
distinct condensin complexes control C. elegans chromosome dynamics. Curr
Biol 19: 9–19.
14. Ja¨ger H, Rauch M, Heidmann S (2005) The Drosophila melanogaster condensin
subunit Cap-G interacts with the centromere-specific histone H3 variant CID.
Chromosoma 113: 350–361.
15. Resnick TD, Dej KJ, Xiang Y, Hawley RS, Ahn C, et al. (2009) Mutations in the
chromosomal passenger complex and the condensin complex differentially affect
synaptonemal complex disassembly and metaphase I configuration in Drosoph-
ila female meiosis. Genetics 181: 875–887.
16. Longworth MS, Herr A, Ji JY, Dyson NJ (2008) RBF1 promotes chromatin
condensation through a conserved interaction with the Condensin II protein
dCAP-D3. Genes Dev 22: 1011–1024.
17. Steffensen S, Coelho PA, Cobbe N, Vass S, Costa M, et al. (2001) A role for
Drosophila SMC4 in the resolution of sister chromatids in mitosis. Curr Biol 11:
295–307.
18. Savvidou E, Cobbe N, Steffensen S, Cotterill S, Heck MM (2005) Drosophila
CAP-D2 is required for condensin complex stability and resolution of sister
chromatids. J Cell Sci 118: 2529–2543.
19. Oliveira RA, Coelho PA, Sunkel CE (2005) The condensin I subunit Barren/
CAP-H is essential for the structural integrity of centromeric heterochromatin
during mitosis. Mol Cell Biol 25: 8971–8984.
20. Dej KJ, Ahn C, Orr-Weaver TL (2004) Mutations in the Drosophila condensin
subunit dCAP-G: defining the role of condensin for chromosome condensation
in mitosis and gene expression in interphase. Genetics 168: 895–906.
21. Cobbe N, Savvidou E, Heck MM (2006) Diverse mitotic and interphase
functions of condensins in Drosophila. Genetics 172: 991–1008.
22. Bhat MA, Philp AV, Glover DM, Bellen HJ (1996) Chromatid segregation at
anaphase requires the barren product, a novel chromosome-associated protein
that interacts with topoisomerase II. Cell 87: 1103–1114.
23. Hartl TA, Sweeney SJ, Knepler PJ, Bosco G (2008) Condensin II resolves
chromosomal associations to enable anaphase I segregation in Drosophila male
meiosis. PLoS Genet 4: e1000228. doi:10.1371/journal.pgen.1000228.
24. Hartl TA, Smith HF, Bosco G (2008) Chromosome alignment and transvection
are antagonized by condensin II. Science 322: 1384–1387.
25. Longworth MS, Walker JA, Anderssen E, Moon NS, Gladden A, et al. (2012) A
shared role for RBF1 and dCAP-D3 in the regulation of transcription with
consequences for innate immunity. PLoS Genet 8: e1002618. doi:10.1371/
journal.pgen.1002618.
26. Gosling KM, Makaroff LE, Theodoratos A, Kim YH, Whittle B, et al. (2007) A
mutation in a chromosome condensin II subunit, kleisin beta, specifically
disrupts T cell development. Proc Natl Acad Sci U S A 104: 12445–12450.
27. Xu Y, Leung CG, Lee DC, Kennedy BK, Crispino JD (2006) MTB, the murine
homolog of condensin II subunit CAP-G2, represses transcription and promotes
erythroid cell differentiation. Leukemia 20: 1261–1269.
28. Oliveira RA, Heidmann S, Sunkel CE (2007) Condensin I binds chromatin early
in prophase and displays a highly dynamic association with Drosophila mitotic
chromosomes. Chromosoma 116: 259–274.
29. James TC, Elgin SC (1986) Identification of a nonhistone chromosomal protein
associated with heterochromatin in Drosophila melanogaster and its gene. Mol
Cell Biol 6: 3862–3872.
30. Kellum R, Raff JW, Alberts BM (1995) Heterochromatin protein-1 distribution
during development and during the cell-cycle in drosophila embryos. J Cell Sci
108: 1407–1418.
31. Shintomi K, Hirano T (2011) The relative ratio of condensin I to II determines
chromosome shapes. Genes Dev 25: 1464–1469.
32. Aono N, Sutani T, Tomonaga T, Mochida S, Yanagida M (2002) Cnd2 has dual
roles in mitotic condensation and interphase. Nature 417: 197–202.
33. Stear JH, Roth MB (2002) Characterization of HCP-6, a C. elegans protein
required to prevent chromosome twisting and merotelic attachment. Genes Dev
16: 1498–1508.
34. Rørth P (1998) Gal4 in the Drosophila female germline. Mech Dev 78: 113–118.
35. Onn I, Aono N, Hirano M, Hirano T (2007) Reconstitution and subunit
geometry of human condensin complexes. EMBO J 26: 1024–1034.
36. Bazile F, St-Pierre J, D’Amours D (2010) Three-step model for condensin
activation during mitotic chromosome condensation. Cell Cycle 9: 3243–3255.
37. Tada K, Susumu H, Sakuno T, Watanabe Y (2011) Condensin association with
histone H2A shapes mitotic chromosomes. Nature 474: 477–483.
38. Yeong FM, Hombauer H, Wendt KS, Hirota T, Mudrak I, et al. (2003)
Identification of a subunit of a novel Kleisin-beta/SMC complex as a potential
substrate of protein phosphatase 2A. Curr Biol 13: 2058–2064.
39. Graveley BR, Brooks AN, Carlson JW, Duff MO, Landolin JM, et al. (2011) The
developmental transcriptome of Drosophila melanogaster. Nature 471: 473–479.
40. Bauer CR, Hartl TA, Bosco G (2012) Condensin II promotes the formation of
chromosome territories by inducing axial compaction of polyploid interphase
chromosomes. PLoS Genet 8: e1002873. doi:10.1371/journal.pgen.1002873.
41. Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering
cell fates and generating dominant phenotypes. Development 118: 401–415.
42. Bischof J, Maeda RK, Hediger M, Karch F, Basler K (2007) An optimized
transgenesis system for Drosophila using germ-line-specific phiC31 integrases.
Proc Natl Acad Sci U S A 104: 3312–3317.
43. Horn C, Wimmer EA (2000) A versatile vector set for animal transgenesis. Dev
Genes Evol 210: 630–637.
44. Gruber S, Arumugam P, Katou Y, Kuglitsch D, Helmhart W, et al. (2006)
Evidence that loading of cohesin onto chromosomes involves opening of its SMC
hinge. Cell 127: 523–537.
45. Venken KJ, He Y, Hoskins RA, Bellen HJ (2006) P[acman]: a BAC transgenic
platform for targeted insertion of large DNA fragments in D. melanogaster.
Science 314: 1747–1751.
46. Schittenhelm RB, Heeger S, Althoff F, Walter A, Heidmann S, et al. (2007)
Spatial organization of a ubiquitous eukaryotic kinetochore protein network in
Drosophila chromosomes. Chromosoma 116: 385–402.
47. Wodarz A, Hinz U, Engelbert M, Knust E (1995) Expression of crumbs confers
apical character on plasma- membrane domains of ectodermal epithelia of
drosophila. Cell 82: 67–76.
48. Weiss A, Herzig A, Jacobs H, Lehner CF (1998) Continuous Cyclin E expression
inhibits progression through endoreduplication cycles in Drosophila. Curr Biol
8: 239–242.
49. Micklem DR, Dasgupta R, Elliott H, Gergely F, Davidson C, et al. (1997) The
mago nashi gene is required for the polarisation of the oocyte and the formation
of perpendicular axes in Drosophila. Curr Biol 7: 468–478.
50. Wen H, Andrejka L, Ashton J, Karess R, Lipsick JS (2008) Epigenetic regulation
of gene expression by Drosophila Myb and E2F2-RBF via the Myb-MuvB/
dREAM complex. Genes Dev 22: 601–614.
51. Schuh M, Lehner CF, Heidmann S (2007) Incorporation of Drosophila CID/
CENP-A and CENP-C into centromeres during early embryonic anaphase.
Curr Biol 17: 237–243.
52. Evan GI, Lewis GK, Ramsay G, Bishop JM (1985) Isolation of monoclonal
antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 5:
3610–3616.
53. Harlow E, Lane D (1988) Antibodies. A Laboratory Manual: Cold Spring
Harbor Laboratory Press.
54. Sullivan W, Ashburner M, Hawley RS (2000) Drosophila protocols. Cold Spring
Harbor, N.Y.: Cold Spring Harbor Laboratory Press. xiv, 697 p. p.
55. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, et al. (2004)
Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome
analysis. Electrophoresis 25: 1327–1333.
Functional Dissection of Drosophila Cap-G
PLOS Genetics | www.plosgenetics.org 17 April 2013 | Volume 9 | Issue 4 | e1003463
